No Data
No Data
No Data
No Data
No Data
Morgan Stanley Maintains Equal-Weight on Galapagos, Maintains $38 Price Target
Morgan Stanley analyst Judah Frommer maintains Galapagos with a Equal-Weight and maintains $38 price target.
Analyst UpgradesApr 23 01:23
LG LAUNCHES VULNERABLE & ENDANGERED SPECIES AWARENESS CAMPAIGN IN TIMES SQUARE
3D anamorphic animal series kicks off LG's Earth Day activations; LG commits $150,000 in partnership with the National Wildlife Federation and Discovery EducationNEW YORK, April 16, 2024 /PRNewswire/
PR NewswireApr 17 00:00
Galapagos NV Unveils CAR-T Therapy Advances
TipRanksApr 8 22:27
Galapagos Showcases Innovative Approach in Hematological Cancer Care With Clinical and Translational Data Presentations at EBMT Congress 2024
Two oral presentations and one poster on encore preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL) / Richter transformation (RT) Mechelen,
GlobeNewswireApr 5 04:01
Galapagos Full Year 2023 Earnings: Beats Expectations
Yahoo FinanceApr 1 15:09
Galapagos NV Announces Shareholders' Meetings and 2023 Report
TipRanksMar 30 06:27
No Data
No Data